• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.

作者信息

Salerno David M, Kovac Danielle, Corbo Heather, Jennings Douglas L, Lee Jennifer, Choe Jason, Scheffert Jenna, Hedvat Jessica, Chen Justin, Tsapepas Demetra, Rosenblatt Russell, Samstein Benjamin, Halazun Karim, Verna Elizabeth, Pereira Marcus, Brennan Corey, Husain Syed A, Mohan Sumit, Brown Robert S

机构信息

Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY, USA.

Division of Pharmacy Practice, Long Island University, New York, NY, USA.

出版信息

Clin Transplant. 2021 Mar;35(3):e14193. doi: 10.1111/ctr.14193. Epub 2021 Jan 5.

DOI:10.1111/ctr.14193
PMID:33336440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7883259/
Abstract
摘要

相似文献

1
SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染会增加实体器官移植受者体内他克莫司的浓度。
Clin Transplant. 2021 Mar;35(3):e14193. doi: 10.1111/ctr.14193. Epub 2021 Jan 5.
2
Rabbit anti-thymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID-19 infection.给予兔抗胸腺细胞球蛋白治疗近期感染新型冠状病毒肺炎的胰肾联合移植受者的排斥反应。
Clin Transplant. 2021 Feb;35(2):e14149. doi: 10.1111/ctr.14149. Epub 2021 Jan 20.
3
Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.缓释他克莫司的药代动力学及其在实体器官移植受者中的应用意义。
Clin Transplant. 2016 Aug;30(8):901-11. doi: 10.1111/ctr.12763. Epub 2016 Jun 18.
4
COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.实体器官移植受者中的新冠病毒肺炎：入住重症监护病房和未入住重症监护病房患者的疾病进展动态及炎症标志物
Transpl Infect Dis. 2020 Oct;22(5):e13407. doi: 10.1111/tid.13407. Epub 2020 Jul 22.
5
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.肾移植患者合并 SARS-CoV-2 感染：布雷西亚肾脏 COVID 工作组经验。
Am J Transplant. 2020 Nov;20(11):3019-3029. doi: 10.1111/ajt.16176. Epub 2020 Aug 2.
6
Is COVID-19 infection more severe in kidney transplant recipients?新冠病毒（COVID-19）感染在肾移植受者中更严重吗？
Am J Transplant. 2021 Mar;21(3):1295-1303. doi: 10.1111/ajt.16424. Epub 2021 Jan 28.
7
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.托珠单抗治疗 5 例 SARS-CoV-2 导致早期 ARDS 的实体和复合组织移植受者。
Am J Transplant. 2020 Nov;20(11):3191-3197. doi: 10.1111/ajt.16080. Epub 2020 Jul 22.
8
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.实体器官移植受者 COVID-19 的临床特征和结局：一项队列研究。
Am J Transplant. 2020 Nov;20(11):3051-3060. doi: 10.1111/ajt.16188. Epub 2020 Jul 28.
9
Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients.SARS-CoV-2 循环阈值在实体器官移植受者中的临床意义。
Am J Transplant. 2021 Mar;21(3):1304-1311. doi: 10.1111/ajt.16357. Epub 2020 Oct 31.
10
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.托珠单抗治疗实体器官移植受者重症 COVID-19：一项匹配队列研究。
Am J Transplant. 2020 Nov;20(11):3198-3205. doi: 10.1111/ajt.16314. Epub 2020 Oct 15.

引用本文的文献

1
Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection.瑞德西韦对感染新冠病毒的移植受者他克莫司血药浓度的潜在影响。
Kidney Int Rep. 2023 Apr 30;8(7):1315-22. doi: 10.1016/j.ekir.2023.04.028.
2
SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染会使Vero E6细胞中临床相关药物代谢酶的表达以及人肺组织中膜转运蛋白的表达失调。
Front Pharmacol. 2023 Apr 27;14:1124693. doi: 10.3389/fphar.2023.1124693. eCollection 2023.
3
How COVID-19 Affects Lung Transplantation: A Comprehensive Review.新型冠状病毒肺炎如何影响肺移植：一项综合综述
J Clin Med. 2022 Jun 18;11(12):3513. doi: 10.3390/jcm11123513.
4
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism.COVID-19 患者肾移植受者中他克莫司暴露增加：炎症驱动的代谢下调作为潜在机制。
Transpl Int. 2022 May 16;35:10269. doi: 10.3389/ti.2022.10269. eCollection 2022.
5
Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection.一名肾移植受者发生突破性严重急性呼吸综合征冠状病毒2感染后出现渗透性肾小管病和急性血栓性微血管病
Kidney Med. 2022 Jul;4(7):100492. doi: 10.1016/j.xkme.2022.100492. Epub 2022 May 26.
6
COVID-19 and Effect on Liver Transplant.新型冠状病毒肺炎及其对肝移植的影响。
Curr Treat Options Gastroenterol. 2021;19(3):483-499. doi: 10.1007/s11938-021-00355-w. Epub 2021 Aug 16.
7
SARS-CoV-2 and Tacrolimus Blood Concentration in Kidney Transplant Recipients.肾移植受者体内的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与他克莫司血药浓度
Kidney Int Rep. 2021 Oct;6(10):2694-2697. doi: 10.1016/j.ekir.2021.07.012. Epub 2021 Jul 15.
8
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic.新型冠状病毒病 2019 与肝移植：大流行第一年的经验教训。
Liver Transpl. 2021 Sep;27(9):1312-1325. doi: 10.1002/lt.26194. Epub 2021 Jul 31.

本文引用的文献

1
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.COVID-19 大流行期间的血栓栓塞和抗凝治疗：抗凝论坛的临时临床指南。
J Thromb Thrombolysis. 2020 Jul;50(1):72-81. doi: 10.1007/s11239-020-02138-z.
2
Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.肾移植受者 2019 冠状病毒病门诊管理的早期结果。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1174-1178. doi: 10.2215/CJN.05170420. Epub 2020 May 18.
3
Management of acute kidney injury in patients with COVID-19.COVID-19 患者急性肾损伤的管理。
Lancet Respir Med. 2020 Jul;8(7):738-742. doi: 10.1016/S2213-2600(20)30229-0. Epub 2020 May 14.
4
Hyperinflammatory shock in children during COVID-19 pandemic.新冠疫情期间儿童的高炎症性休克
Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1. Epub 2020 May 7.
5
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴：炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.
6
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.COVID-19 于实体器官移植受者：来自美国震中地区的初步报告。
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
7
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
8
Impact of Interleukin-6 on Drug-Metabolizing Enzymes and Transporters in Intestinal Cells.白细胞介素-6 对肠道细胞中药物代谢酶和转运体的影响。
AAPS J. 2019 Dec 20;22(1):16. doi: 10.1208/s12248-019-0395-x.
9
Addressing phenoconversion: the Achilles' heel of personalized medicine.应对表型转换：个性化医疗的致命弱点。
Br J Clin Pharmacol. 2015 Feb;79(2):222-40. doi: 10.1111/bcp.12441.